Snippets | GenomeWeb



TrimGen Gets FDA OK for Warfarin Genotyping Test

TrimGen has received US Food and Drug Administration 510(k) clearance for its eQ-PCR Warfarin Genotyping kit, the Sparks, Md.-based firm said this week.

The TrimGen kit tests for SNPs in the VKORC1 and cytochrome P450 CYP2C9 genes, which serve as clinically relevant predictors of warfarin dosing. The assay is used to aid physicians in identifying patients who may be at risk of warfarin sensitivity.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.